Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Ovarian Neoplasms

  Free Subscription


15.07.2019

1 Am J Obstet Gynecol
1 Am J Surg Pathol
1 Cancer Lett
1 Clin Cancer Res
1 Gynecol Oncol
1 J Natl Cancer Inst
2 Lancet Oncol
3 Oncogene
1 Oncology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Obstet Gynecol

  1. TARNEY CM, Wang G, Bateman NW, Conrads KA, et al
    Biomarker Panel for Early Detection of Endometrial Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Am J Obstet Gynecol. 2019 Jul 4. pii: S0002-9378(19)30769.
    PubMed     Text format     Abstract available


    Am J Surg Pathol


  2. Ovarian Microcystic Stromal Tumors are Characterized by Alterations in the Beta-Catenin-APC Pathway and May be an Extracolonic Manifestation of Familial Adenomatous Polyposis.
    Am J Surg Pathol. 2017 Oct 26. doi: 10.1097/PAS.0000000000000981.
    PubMed     Text format    


    Cancer Lett

  3. PARAYATH NN, Gandham SK, Leslie F, Amiji MM, et al
    Improved anti-tumor efficacy of paclitaxel in combination with MicroRNA-125b-based tumor-associated macrophage repolarization in epithelial ovarian cancer.
    Cancer Lett. 2019;461:1-9.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  4. LI Z, Zhou W, Zhang Y, Sun W, et al
    ERK regulates HIF-1alpha-mediated platinum resistance by directly targeting PHD2 in ovarian cancer.
    Clin Cancer Res. 2019 Jul 8. pii: 1078-0432.CCR-18-4145.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  5. MATSUO K, Huang Y, Zivanovic O, Shimada M, et al
    Effectiveness of postoperative chemotherapy for stage IC mucinous ovarian cancer.
    Gynecol Oncol. 2019 Jul 3. pii: S0090-8258(19)31337.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  6. TOMAO F, Panici PB, Tomao S
    RE: Universal tumor DNA BRCA1/2 testing of ovarian cancer: prescreening PARPi treatment and genetic predisposition.
    J Natl Cancer Inst. 2019 Jul 9. pii: 5530203. doi: 10.1093.
    PubMed     Text format    


    Lancet Oncol

  7. NENE NR, Reisel D, Leimbach A, Franchi D, et al
    Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study.
    Lancet Oncol. 2019 Jul 9. pii: S1470-2045(19)30340.
    PubMed     Text format     Abstract available

  8. VERSTRAELEN H
    Of microbes and women: BRCA1, vaginal microbiota, and ovarian cancer.
    Lancet Oncol. 2019 Jul 9. pii: S1470-2045(19)30406.
    PubMed     Text format    


    Oncogene

  9. HARDY LR, Pergande MR, Esparza K, Heath KN, et al
    Proteomic analysis reveals a role for PAX8 in peritoneal colonization of high grade serous ovarian cancer that can be targeted with micelle encapsulated thiostrepton.
    Oncogene. 2019 Jul 11. pii: 10.1038/s41388-019-0842.
    PubMed     Text format     Abstract available

  10. CHEN X, Mangala LS, Mooberry L, Bayraktar E, et al
    Identifying and targeting angiogenesis-related microRNAs in ovarian cancer.
    Oncogene. 2019 Jul 9. pii: 10.1038/s41388-019-0862.
    PubMed     Text format     Abstract available

  11. MAJEM B, Parrilla A, Jimenez C, Suarez-Cabrera L, et al
    MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways.
    Oncogene. 2019 Jul 5. pii: 10.1038/s41388-019-0860.
    PubMed     Text format     Abstract available


    Oncology

  12. MARKMAN M
    The Evolving Arena of Ovarian Cancer Maintenance Therapy.
    Oncology. 2019 Jul 9:1-4. doi: 10.1159/000501618.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: